Glassia Side Effects
Generic name: alpha 1-proteinase inhibitor
Note: This document contains side effect information about alpha 1-proteinase inhibitor. Some of the dosage forms listed on this page may not apply to the brand name Glassia.
Some side effects of Glassia may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to alpha 1-proteinase inhibitor: intravenous powder for injection, intravenous solution
Get emergency medical help if you have any of these signs of an allergic reaction while taking alpha 1-proteinase inhibitor (the active ingredient contained in Glassia) hives; wheezing, difficulty breathing; feeling like you might pass out; swelling of your face, lips, tongue, or throat.
Stop using alpha 1-proteinase inhibitor and call your doctor at once if you have a serious side effect such as:
-
fever, chills, body aches, flu symptoms, sores in your mouth and throat;
-
pain or burning when you urinate;
-
wheezing, chest pain or tightness, trouble breathing; or
-
vision changes.
Less serious side effects of alpha 1-proteinase inhibitor may include:
-
nausea, bloating;
-
headache, dizziness, drowsiness;
-
feeling tired;
-
back pain, joint or muscle pain;
-
swelling in your hands or feet;
-
flushing (warmth, redness, or tingly feeling);
-
cold symptoms such as stuffy nose, sneezing, sore throat, cough; or
-
mild itching.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects.
For Healthcare Professionals
Applies to alpha 1-proteinase inhibitor: intravenous powder for injection, intravenous solution
Respiratory
Respiratory side effects have included chest pain, pharyngitis, asthma, rhinitis, bronchitis, sinusitis, increased cough, upper and lower respiratory tract infections, dyspnea, chronic obstructive pulmonary disease (COPD) exacerbation, nasopharyngitis, pharyngolaryngeal pain, COPD, sore throat, bronchospasm, lung disorder, infective exacerbation of COPD, bilateral pulmonary infiltrates, and diffuse interstitial lung disease. Dyspnea has been reported during postmarketing experience.
Nervous system
Nervous system side effects have included dizziness, headache, somnolence, dysgeusia, lethargy, lightheadedness, paresthesia, and migraine.
Other
Other side effects have included pain, back pain, viral infection, peripheral edema, chills, fever, chest pain, chest discomfort, influenza-like illness, pyrexia, delayed fever, influenza-like symptoms, allergic-like reactions, malaise, hot flush, asthenia, infection, and accidental injury. Chest pain, chills, and influenza-like illness have been reported during postmarketing experience.
Cardiovascular
Cardiovascular side effects have included vasodilation, hypertension, tachycardia, hypotension, and transient increase in blood pressure. Tachycardia, hypotension, and hypertension (including transient increases of blood pressure) have been reported during postmarketing experience.
Hematologic
Hematologic side effects have included decreased platelet count, transient leukocytosis, dilutional anemia, ecchymosis, and hemorrhage.
Dermatologic
Dermatologic side effects have included pruritus, rash, erythema marginatum, and urticaria. Rash has been reported during postmarketing experience.
Gastrointestinal
Gastrointestinal side effects have included bloating, nausea, abdominal pain, diarrhea, and dyspepsia.
Hepatic
Hepatic side effects have included elevations (greater than 2 times the upper limit of normal) in aminotransferases (ALT or AST), increased hepatic enzyme (unspecified), and cholangitis.
Musculoskeletal
Musculoskeletal side effects have included musculoskeletal discomfort, joint swelling, arthralgia, and myalgia.
Ocular
Ocular side effects have included abnormal vision.
Local
Local side effects have included injection site pain, injection site hemorrhage, and injection site reaction.
Genitourinary
Genitourinary side effects have included urinary tract infection.
Hypersensitivity
Hypersensitivity side effects have included hypersensitivity during postmarketing experience.
More Glassia resources
- Glassia Consumer Overview
- Glassia Prescribing Information (FDA)
- Glassia solution MedFacts Consumer Leaflet (Wolters Kluwer)
- Glassia Advanced Consumer (Micromedex) - Includes Dosage Information
- Aralast NP MedFacts Consumer Leaflet (Wolters Kluwer)
- Aralast NP Prescribing Information (FDA)
- Prolastin-C Prescribing Information (FDA)
- Zemaira Prescribing Information (FDA)
- Zemaira Consumer Overview
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of information provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.


